Increased investment in vaccines key to reducing sexually transmitted infections
Sexually transmitted infections (STIs) are a massive health challenge with more than a million new infections occurring every day.
Increased investment in research and development for new vaccines is key to halting the spread of genital herpes, gonorrhoea, chlamydia, syphilis, and trichomoniasis, according to a new special issue of the journal Vaccine, co-edited by WHO and the United States’ National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH).
Availability and price of inactivated polio vaccine
The Global Polio Eradication Initiative (GPEI) and the GAVI Alliance welcome the conclusion of UNICEF’s tender process, which makes accessible sufficient quantities of affordable inactivated polio vaccine (IPV) to support country introductions, in line with the ambitious timeline of GPEI’s Eradication and Endgame Strategic Plan 2013-2018.
The vaccine will now be available to GAVI-supported countries for as little as EUR 0.75 per dose in ten-dose vials.
The first mass vaccination campaign conducted in Africa with a vaccine that does not require constant refrigeration succeeded in providing complete coverage while ensuring the vaccine stayed viable even in ambient temperatures up to 39°C, according to a study published online today in the journal Vaccine.
New mortality estimates from WHO show that annual measles deaths have reached historic lows, dropping 78% from more than 562 000 in 2000 to 122 000 in 2012.
During this time period, an estimated 13.8 million deaths have been prevented by measles vaccination and surveillance data showed that reported cases declined 77% from 853 480 to 226 722.
78%drop in global measles deathsGlobal control and regional elimination of measles
83%of infants vaccinated with 3 doses of DTP vaccine in 20122012 global vaccination coverage
22.6 millionchildren incompletely vaccinated at 12 months of ageGlobal immunization goals